Enzo Biochem (NYSE:ENZ) named Matthew Kupferberg as the company’s in-house general counsel.
He was most recently general counsel, chief compliance officer and privacy officer of Digital Medical Technologies, a medication adherence technology company.
“With this addition, we are continuing to bring new levels of experience and insight to our executive and mid-level management teams as we work toward our goal of significantly expanding our portfolio of innovative product and service offerings in biotechnology and diagnostics,” Hamid Erfanian, CEO of Enzo, said in a statement.
“Enzo remains actively engaged in a search to augment our executive team,” he added. “This newly formed position dovetails with the Enzo executive team’s strategic initiatives, including accelerating the path to regulatory review for our molecular platforms while delivering on the company’s cost savings initiatives.”
Mr. Kupferberg brings a plethora of experiences to Enzo, including leading transactional and legal activities for health and wellness companies and providing counsel regarding corporate governance issues. He has worked with payers, PBMs, providers and medical device manufacturers, assisting multi-billion-dollar corporations to negotiate and structure complex health care arrangements.
